Co-cultured with peptide-pulsed monoallelic HLA class I-expressing targets, TCR-transduced CD4+ effectors recognized their cognate antigens within HLA class I restriction, suggesting that the HLA class II positive melanoma TME is rich in neoantigen-specific Treg cells. The gene discussed is CD4; the disease is melanoma.